Home
>
National Drug Code (NDC)
>
Risperidone
Risperidone - 51079-345-05 - (risperidone)
Drug Information of Risperidone
| Product NDC: | 51079-345 |
| Proprietary Name: | Risperidone |
| Non Proprietary Name: | risperidone |
| Active Ingredient(s): | 1 mg/1 & nbsp; risperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Risperidone
| Product NDC: | 51079-345 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091537 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120919 |
Package Information of Risperidone
| Package NDC: | 51079-345-05 |
| Package Description: | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-345-05) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-345-01) |
NDC Information of Risperidone
| NDC Code | 51079-345-05 |
| Proprietary Name | Risperidone |
| Package Description | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-345-05) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-345-01) |
| Product NDC | 51079-345 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | risperidone |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20120919 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | RISPERIDONE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
